News Search Results
Aug 20, 2024, 21:40 ET GenScript Launches Global Philanthropy Platform: The GenTeer Program
making a real difference for those in need. This year, the company plans to center its initiatives around core ESG issues, with a special focus on biotechnology, emphasizing "supporting biotech education" as the annual theme. Global volunteer teams will tailor their action plans to local needs, encouraging
More news about: GenScript Biotech Corporation
Aug 20, 2024, 14:19 ET Careington Announces New Chief Information Officer Anthony Mustoe
Mustoe brings with him more than 25 years of experience as a seasoned technology leader in a wide variety of industries, including health care, biotechnology, telecommunications, hospitality and more. Prior to joining Careington, he served as the chief information officer of a publicly traded biotech
More news about: Careington International Corporation
Aug 20, 2024, 10:00 ET VGXI accepted as a Member of the Biopharmaceutical Manufacturing Preparedness (BioMap) Consortium
GeneOne Life Science Inc. ("GeneOne" KOSPI: 011000) headquartered in Seoul, South Korea is an international biotechnology company and a leading contract manufacturer of DNA plasmids for use in vaccines, gene therapies, and cell therapies. GeneOne has recently expanded
More news about: VGXI, Inc.
Aug 20, 2024, 09:00 ET OTEZLA® (APREMILAST) NOW AVAILABLE IN THE U.S. FOR MODERATE TO SEVERE PEDIATRIC PLAQUE PSORIASIS
to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing
More news about: Amgen
Aug 20, 2024, 08:55 ET Neomorph Announces Appointment of Dr. Peter Lebowitz, M.D., Ph.D. to its Board of Directors
Hematology/Oncology fellowship at the National Cancer Institute, National Institute of Health. About Neomorph Neomorph is a biotechnology company solving critical problems in human health through the discovery and development of innovative new medicines against 'undruggable' targets.
More news about: Neomorph
Aug 20, 2024, 06:45 ET Tirzepatide reduced the risk of developing type 2 diabetes by 94% in adults with pre-diabetes and obesity or overweight
life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Aug 20, 2024, 06:27 ET MAHE signs MoU with SKAN and Happiest Health for academics, research and consultancy
through rigorous academic inquiry and pioneering research. With our strong foundation in research, particularly in areas like molecular biology, biotechnology, and clinical research, we are excited to collaborate with SKAN and Happiest Health. This partnership not only enhances our capabilities but also
More news about: SKAN Research Trust
Aug 19, 2024, 19:00 ET Rakuten Medical Announces New Management Team to Drive the Next Phase of Growth and Innovation
DIEGO, Aug. 19, 2024 /PRNewswire/ -- Rakuten Medical, Inc., a global biotechnology company developing and commercializing oncology precision, cell-targeting photoimmunotherapy through its proprietary Alluminox™ platform, announces
More news about: Rakuten Medical, Inc.
Aug 19, 2024, 10:01 ET Real-world Evidence Solutions Market to be Worth $6.37 Billion by 2031--Exclusive Report by Meticulous Research®
evidence (RWE). The resulting clinical evidence covers the use of a medical product and its possible advantages or disadvantages. Pharmaceutical, biotechnology, and medical device firms, as well as healthcare payers and providers, employ RWE solutions for market access and reimbursement/coverage choices,
More news about: Meticulous Market Research Pvt. Ltd.
Aug 19, 2024, 09:30 ET SalioGen Therapeutics Appoints Kali Stasi, M.D., Ph.D. as Chief Medical Officer
Mass., Aug. 19, 2024 /PRNewswire/ -- SalioGen Therapeutics, a biotechnology company developing next-generation genetic medicines based on its novel Gene Coding™ technology, today announced the appointment of Kalliopi "Kali"
More news about: SalioGen Therapeutics
Aug 19, 2024, 09:00 ET BioMarin to Host 2024 Investor Day on September 4th in New York
will be available online shortly after the live webcast is completed. About BioMarinFounded in 1997, BioMarin is a global biotechnology Company dedicated to transforming lives through genetic discovery. The Company develops and commercializes targeted therapies that address the root
More news about: BioMarin Pharmaceutical Inc.
Aug 19, 2024, 09:00 ET TuHURA Biosciences and Kintara Therapeutics Announce Kineta Inc. Reopens Enrollment for VISTA-101 Clinical Trial Evaluating KVA12123 in Patients with Advanced Solid Tumor Cancer
company focused on the development of new solid tumor cancer therapies, today announced that Kineta, Inc. (Nasdaq: KA) ("Kineta"), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, has reopened enrollment in its ongoing
More news about: Kintara Therapeutics
Aug 19, 2024, 08:45 ET Catalyst Clinical Research Again Named One of the Fastest-Growing Private Companies
Catalyst Clinical Research, a clinical research organization (CRO), provides highly customizable solutions to the global biopharmaceutical and biotechnology industries through two established solutions:
More news about: Catalyst Clinical Research
Aug 19, 2024, 08:30 ET Perrigo Appoints David Ball to the Newly Created Position of Executive Vice President and Chief Brand and Digital Officer
England, which adds a unique dimension to his consumer goods expertise. His scientific background, combined with his experience in biotechnology, provides a valuable perspective on innovation and sustainable practices. About Perrigo Perrigo Company plc (NYSE:
More news about: Perrigo Company plc
Aug 19, 2024, 08:00 ET RNA Therapeutics Receives Feedback from FDA for the First-in-class mRNA-based Delivery of Therapeutic Protein Promising Affordable Biological Drugs
CHICAGO, Aug. 19, 2024 /PRNewswire/ -- RNA Therapeutics, a clinical-stage biotechnology company focused on innovative applications of mRNA-based delivery systems for therapeutic proteins and vaccines, announced that it has received
More news about: RNA Therapeutics, Inc.
Aug 19, 2024, 08:00 ET GlycoNex Successfully Completes Phase 1 Study of Denosumab Biosimilar, SPD8
Aug. 19, 2024 /PRNewswire/ -- GlycoNex (4168, hereinafter referred to as GNX), a clinical stage biotechnology company focused on the development of glycan-directed cancer therapies, today announced the successful completion of a Phase 1 clinical trial of
More news about: GlycoNex, Inc.
Aug 19, 2024, 08:00 ET China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025
fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that through Hainan Helpson Medical and Biotechnology Co., Ltd. ("Helpson"), our wholly owned subsidiary, it expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025 in
More news about: China Pharma Holdings, Inc.
Aug 19, 2024, 08:00 ET Arthrosi Therapeutics Receives FDA Fast Track Designation for AR882 in Tophaceous Gout
DIEGO, Aug. 19, 2024 /PRNewswire/ -- Arthrosi Therapeutics, Inc., a late-stage biotechnology company developing a potentially best-in-class, highly potent and selective next generation URAT1 inhibitor to treat gout, today announced the U.S.
More news about: Arthrosi Therapeutics
Aug 19, 2024, 07:45 ET Latigo Biotherapeutics Announces Positive Phase 1 Data for Lead Non-Opioid Pain Medicine Candidate and Appoints Neil Singla, M.D., Chief Medical Officer
alternatives and mitigate the opioid epidemic. About Latigo BiotherapeuticsLatigo Biotherapeutics is a private clinical-stage biotechnology company developing innovative non-opioid pain medicines with potential best-in-class profiles that directly target the source of pain. Latigo's
More news about: Latigo Biotherapeutics
Aug 19, 2024, 07:00 ET RedHill Announces Positive Obesity and Diabetes Results with Opaganib
specialty biopharmaceutical company, today announced positive results from multiple in vivo studies, undertaken by RedHill's partner, Apogee Biotechnology Corporation, showing the impact of opaganib[2] on weight gain and glucose tolerance in a high fat diet (HFD) model, supporting the potential
More news about: RedHill Biopharma Ltd.
Aug 19, 2024, 03:57 ET Allozymes and Adisseo Partner on Next-Gen Animal Feed Production Using Rapid Microfluidics Technology
methods, paving the way for a more sustainable future for animal agriculture. About Allozymes Allozymes is a fast-growing biotechnology company that applies its proprietary ultra-high-throughput platform technology to rapidly develop novel enzymes and unlock the bioeconomy across
More news about: Allozymes
Aug 18, 2024, 08:26 ET 2024 World Life Science Conference Scheduled for October 19 in Hainan, China
other countries are expected to participate. The 2024 World Life Science Conference will concentrate on the frontiers of life sciences, biotechnology trends, and health issues of public concern, facilitating high-level academic exchanges and showcasing the latest achievements. In addition, the
More news about: 2024 World Life Science Conference
Aug 18, 2024, 08:20 ET 2024 World Life Science Conference Scheduled for October 19 in Hainan, China
other countries are expected to participate. The 2024 World Life Science Conference will concentrate on the frontiers of life sciences, biotechnology trends, and health issues of public concern, facilitating high-level academic exchanges and showcasing the latest achievements. In addition, the
More news about: 2024 World Life Science Conference
Aug 18, 2024, 00:46 ET Fapon Biotech Delivers Antigen Diagnostic Solutions to Help Control Monkeypox Outbreak in Africa
global leading in vitro diagnostics (IVD) enterprise, Fapon Biotech Inc. (referred to as "Fapon Biotech") focuses on the future needs and trends of biotechnology development and is committed to providing global partners with high-performance IVD reagent raw materials, reagent services and innovative open
More news about: Fapon Biotech Inc.
Aug 17, 2024, 10:00 ET SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Moderna, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRNA
[Click here for information about joining the class action] Moderna is a biotechnology company that discovers, develops, and commercializes messenger RNA ("mRNA") therapeutics and vaccines for the treatment of infectious diseases,
More news about: Pomerantz LLP